Who is sponsoring NCT03675698?

NCT03675698 is sponsored by Rajiv Gandhi Cancer Institute & Research Center, India.

What drugs are being tested in NCT03675698?

Interventions in NCT03675698: Nasotracheal Intubation.

What condition does NCT03675698 study?

NCT03675698 studies Nasotracheal Tube Passage Through Nasal Cavity.

Is NCT03675698 still recruiting?

NCT03675698 is currently completed. Last updated 17 June 2020.

Last reviewed 2020-06-17 · How we verify

NCT03675698: RINSE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Radiological Images for Nasotracheal Tube Size Estimation

Completed Last updated 17 June 2020

What this trial tests

trial testing Nasotracheal Intubation in Nasotracheal Tube Passage Through Nasal Cavity in 100 participants. Completed in 10 March 2020.

Timeline

25 October 2018

Primary endpoint
24 October 2019

10 March 2020

Quick facts

Lead sponsor	Rajiv Gandhi Cancer Institute & Research Center, India
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	25 October 2018
Primary completion	24 October 2019
Estimated completion	10 March 2020
Sites	1 location across India

Drugs / interventions tested

Nasotracheal Intubation

Conditions studied

Nasotracheal Tube Passage Through Nasal Cavity — all drugs for Nasotracheal Tube Passage Through Nasal Cavity →

Sponsor

Rajiv Gandhi Cancer Institute & Research Center, India

Who can join

Adults 18 to 65, any sex, with Nasotracheal Tube Passage Through Nasal Cavity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This trial is planned to estimate the size of nasotracheal tube (NTT) by calculating the diameter of both nasal cavity in radiological images of nose (CT scan/MRI) at the level below the inferior turbinate and floor of nose in coronal planes. Smallest diameter will be considered to calculate the outer diameter of NTT, hence the size .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Rajiv Gandhi Cancer Institute & Research Center, India trials

Trials by the same sponsor.

NCT07258797 — Short Course or Long Course Radiotherapy as Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer · NA · not yet recruiting
NCT06026475 — Role of Goal Directed Fluid Therapy in Enhanced Recovery After Surgery in Gastro-intestinal Oncosurgeries · NA · completed
NCT05439109 — Correct Endotracheal Tube Placement Using Topographical Landmarks · NA · unknown
NCT05721391 — Impact of Frailty on Postoperative Complications in Oncosurgery · completed
NCT05142163 — Stroke Volume Variation and Plethysmography Variability Index as Goal Directed Fluid Therapy in Major Oncosurgeries · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03675698 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rajiv Gandhi Cancer Institute & Research Center, India
Last refreshed: 17 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03675698.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing